If you or a friend or loved one has recently been diagnosed with pulmonary fibrosis (PF), you probably have a lot of questions. Very little is known about this chronic lung condition, ... Read more
Patients treated with Ofev (nintedanib) or Esbriet (pirfenidone) for pulmonary fibrosis in a real-world setting have similar rates of side effects as those reported in clinical trials testing the drugs, despite ... Read more
Certain immune cells, called monocyte-derived alveolar macrophages, may contribute to lung inflammation and fibrosis, according to the results of a new study. Researchers believe that therapies targeting these monocyte-derived macrophages may ... Read more
Vanderbilt University researchers are sponsoring the first major study of a rare lung disease that disproportionately affects people from Puerto Rico and can cause pulmonary fibrosis. Called Hermansky-Pudlak syndrome (HPS), the ... Read more
Pulmonary rehabilitation mixture (PRM), an herbal-based formula used for decades in Chinese traditional medicine, has therapeutic potential against pulmonary fibrosis (PF) progression by targeting several molecular factors known to be involved ... Read more
The McDonnell Genome Institute at Washington University has received a $10 million U.S. government grant to map the DNA of patients from a number of ethnic groups who had chronic obstructive pulmonary disease ... Read more
Pulmonary fibrosis (PF) patients with lung cancer have alterations in 14 cancer-driver genes, a new French study analyzing cancer samples from PF patients reported. The study is titled, “Morphologic and molecular study of lung ... Read more
The Pulmonary Fibrosis Foundation (PFF) has enlisted former New York Yankees baseball champion Bernie Williams to help lobby U.S. lawmakers for more federal funds to develop safe and effective therapies for an incurable ... Read more
Pulmonary fibrosis (PF) is a chronic and progressive lung disease where the air sac in the lungs (alveoli) becomes scarred and stiff making it difficult to breathe and get enough oxygen ... Read more
Lung Therapeutics, which specializes in therapies for fibrosis, lung injury and lung disease, announced that it has raised $14.3 million in Series B financing. The funding will support ongoing clinical trials in Australia ... Read more
